Belamcanda chinensis

Common Names: blackberry lily

Ethnobotanical Studies

Studies

Belamcanda chinensis extract inhibits non-small cell lung cancer proliferation and induces apoptosis via inhibiting the MAPK (Ras/Raf) and Akt pathways.

Summary

BCE from traditional Chinese medicine inhibits NSCLC cell growth by inducing apoptosis and blocking key signaling pathways, suggesting potential as a treatment for NSCLC, particularly in patients with Ras or Raf mutations.

Ma C et al (2024).
Heliyon.
PubMed:
39229537

Irilin D suppresses RANKL-induced osteoclastogenesis and prevents inflammation-induced bone loss by disrupting the NF-κB and MAPK signaling pathways.

Gal M et al (2024).
Eur J Pharmacol.
PubMed:
39209096

Efficient degradation and enhanced anticomplementary activity of Belamcanda chinensis (L.) DC. polysaccharides via trifluoroacetic acid treatment with different degrees.

Duan Y et al (2024).
Int J Biol Macromol.
PubMed:
39084989

Herbal textual research of Belamcanda chinensis (L.) redouté and screening of quality-markers based on 'pharmacodynamics-substance'.

Review
Wang Z et al (2024).
J Ethnopharmacol.
PubMed:
38754643

An arabinose-rich heteropolysaccharide isolated from Belamcanda chinensis (L.) DC treats liver cancer by targeting FAK and activating CD40.

Summary

BCP80-2 polysaccharide from Belamcanda chinensis inhibits tumor growth, metastasis, and angiogenesis in zebrafish. It suppresses cell migration via FAK pathway and boosts immune response.

Zhao Y et al (2024).
Carbohydr Polym.
PubMed:
38388048

First report of Phaeosphaeria caricicola causing leaf spot on Belamcanda chinensis in China.

Tang Z et al (2024).
Plant Dis.
PubMed:
38197883

Sucrosephenylpropanoid esters and isoflavonoids isolated from Belamcanda chinensis roots and their potential anti-osteoclastogenic activity.

Ha MT et al (2023).
Bioorg Chem.
PubMed:
38185009

Exploring Asthma Mechanism of Belamcanda Chinensis by "Dose-effect Weighted Coefficient" Network Pharmacology and Experiment Validation.

Summary

Belamcanda chinensis (BC), a traditional Chinese medicine, has anti-inflammatory and immune regulatory properties that can help counteract asthma, a serious and chronic inflammatory disease of the airways. This research is important for finding potential treatments for asthma.

Zhang K et al (2023).
Comb Chem High Throughput Screen.
PubMed:
38155401

Three rare nor-sesquiterpenoids with lipid-lowering activity from Belamcanda chinensis.

Qianshi Y et al (2023).
Org Biomol Chem.
PubMed:
38019684

Preparation and photothermal therapy of gold nanorods modified by Belamcanda chinensis (L.) DC polysaccharide.

Zhao Y et al (2023).
Int J Biol Macromol.
PubMed:
37935290

Impact of tectoridin on the pharmacokinetics of florfenicol via targeting cytochrome P450 and P-glycoprotein of rats.

Zhang M et al (2023).
Xenobiotica.
PubMed:
37781957

Study on quality difference between Belamcanda chinensis (L.) DC and Iris tectorum Maxim. based on chemical chromatogram analysis, biological activity evaluation and in vivo distribution rule.

Xiong H et al (2023).
J Ethnopharmacol.
PubMed:
37634753

Functional characterization and structural basis of a reversible glycosyltransferase involves in plant chemical defence.

Cheng W et al (2023).
Plant Biotechnol J.
PubMed:
37581303

Cytotoxic Compounds from Belamcanda chinensis (L.) DC Induced Apoptosis in Triple-Negative Breast Cancer Cells.

Summary

A recent study identified several compounds isolated from a specific plant species. These compounds were tested for their effects on tumor cell growth and metastasis. One compound in particular showed significant activity against two different types of breast cancer cells. Further investigation revealed that this compound caused cell cycle arrest, mitochondrial damage, and cell apoptosis. These findings suggest that this compound could be a potential treatment for triple-negative breast cancer. More research is needed to fully evaluate its effectiveness.

Guo YP et al (2023).
Molecules.
PubMed:
37375271

Irigenin attenuates lipopolysaccharide-induced acute lung injury by inactivating the mitogen-activated protein kinase (MAPK) signaling pathway.

Liu D et al (2023).
Hum Exp Toxicol.
PubMed:
36738242

Medicinal Importance, Pharmacological Activity and Analytical Aspects of Flavonoid 'Irisflorentin' from Belamcanda chinensis (L.) DC.

Patel DK et al (2023).
Curr Drug Res Rev.
PubMed:
36733196

[Identification, biological characterization, and fungicide screening of pathogens causing leaf spot of Belamcanda chinensis].

Yang YW et al (2022).
Zhongguo Zhong Yao Za Zhi.
PubMed:
36471928

Ultrasonic-assisted extraction, fatty acids identification of the seeds oil and isolation of chemical constituent from oil residue of Belamcanda chinensis.

Liu P et al (2022).
Ultrason Sonochem.
PubMed:
36265291

Comparison Analysis Based on Complete Chloroplast Genomes and Insights into Plastid Phylogenomic of Four Iris Species.

Feng JL et al (2022).
Biomed Res Int.
PubMed:
35937412

Isolation, Characterization and Anticomplementary Activity of Polysaccharides from the Rhizomes of Belamcanda chinensis (L.) DC.

Duan Y et al (2022).
Chem Biodivers.
PubMed:
35841390

UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro.

Li J, Xu Z and Gu J (2022).
Molecules.
PubMed:
35807350

Anti-Nociceptive and Anti-Inflammatory Activities of the Ethyl Acetate Extract of Belamcanda chinensis (L.) Redouté in Raw 264.7 Cells in vitro and Mouse Model in vivo.

He X et al (2022).
J Pain Res.
PubMed:
35502404

Dual-Directional Regulation of Belamcanda chinensis Extract on Ovalbumin-Induced Asthma in Guinea Pigs of Different Sexes Based on Serum Metabolomics.

Summary

This study found that extract improved asthma symptoms in guinea pigs by affecting immune mechanisms, inflammation, nerve metabolism, and energy metabolism. The treatment effects varied based on sex.

Liu J et al (2022).
Evid Based Complement Alternat Med.
PubMed:
35399628

New iridal-type triterpenoid analogues with 6/5/6-fused carbon skeleton from the rhizomes of Belamcanda chinensis.

Li J et al (2022).
Fitoterapia.
PubMed:
34968640

Isoflavones of Belamcanda chinensis.

Yamaki M et al (1990).
Planta Med.
PubMed:
17221435

Isoflavonoids from Belamcanda chinensis.

Ito H, Onoue S and Yoshida T (2001).
Chem Pharm Bull (Tokyo).
PubMed:
11558622